about
Spatial correlation between brain aerobic glycolysis and amyloid-β (Aβ ) depositionRegional aerobic glycolysis in the human brainAmyloid plaques disrupt resting state default mode network connectivity in cognitively normal elderlyAlzheimer disease and cognitive reserve: variation of education effect with carbon 11-labeled Pittsburgh Compound B uptakeAltered emotional interference processing in affective and cognitive-control brain circuitry in major depressionDecreased hippocampal 5-HT2A receptor binding in major depressive disorder: in vivo measurement with [18F]altanserin positron emission tomographyA quantitative model for the in vivo assessment of drug binding sites with positron emission tomographyImproved assessment of significant activation in functional magnetic resonance imaging (fMRI): use of a cluster-size thresholdBlood flow and oxygen delivery to human brain during functional activity: theoretical modeling and experimental data.Brain work and brain imaging.The hippocampus and depression.Diffuse microstructural abnormalities of normal-appearing white matter in late life depression: a diffusion tensor imaging study.Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer diseaseSevere hippocampal atrophy is not associated with depression in temporal lobe epilepsy.Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: implications for future clinical trials of Alzheimer's diseasePET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with 18F-AV-133 (florbenazine) in patients with Alzheimer's disease and Lewy body disorders.Blast-related brain injury: imaging for clinical and research applications: report of the 2008 st. Louis workshop.Antidepressant treatment normalizes hypoactivity in dorsolateral prefrontal cortex during emotional interference processing in major depressionEvaluation of 5-ethynyl-2'-deoxyuridine staining as a sensitive and reliable method for studying cell proliferation in the adult nervous systemNeuropathologic heterogeneity does not impair florbetapir-positron emission tomography postmortem correlatesAPOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging.Cortical binding of pittsburgh compound B, an endophenotype for genetic studies of Alzheimer's disease.Correlation between two methods of florbetapir PET quantitative analysis.Resting-state functional MRI in depression unmasks increased connectivity between networks via the dorsal nexusRegional white matter hyperintensity burden in automated segmentation distinguishes late-life depressed subjects from comparison subjects matched for vascular risk factors.Cognitively unimpaired HIV-positive subjects do not have increased 11C-PiB: a case-control study.Alzheimer disease identification using amyloid imaging and reserve variables: proof of concept.Development of a PET radiotracer for non-invasive imaging of the reactive oxygen species, superoxide, in vivoAmyloid-beta plaque growth in cognitively normal adults: longitudinal [11C]Pittsburgh compound B data.Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study.Exercise and Alzheimer's disease biomarkers in cognitively normal older adults.Nonoxidative glucose consumption during focal physiologic neural activity.Enhanced detection of focal brain responses using intersubject averaging and change-distribution analysis of subtracted PET images.Positive florbetapir PET amyloid imaging in a subject with frequent cortical neuritic plaques and frontotemporal lobar degeneration with TDP43-positive inclusions.Relationship of dementia screening tests with biomarkers of Alzheimer's disease.Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study.Decreased hippocampal 5-HT(2A) receptor binding in older depressed patients using [18F]altanserin positron emission tomography.A possible substrate for dopamine-related changes in mood and behavior: prefrontal and limbic effects of a D3-preferring dopamine agonistYKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's diseaseNoninvasive estimation of the arterial input function in positron emission tomography imaging of cerebral blood flow
P50
Q24631814-13FBCD9B-9D2E-4D5F-91C0-89054B54C2BFQ24631922-6FAF1F25-351B-484E-87B1-DF28C54AFB19Q24634788-16C1E938-FC62-494C-80A4-57E829A63FC2Q24646913-87580C25-A503-4793-858B-B067190E1E85Q24652455-122E5732-6858-49FD-8592-707856CE5742Q28240774-AFA6803D-E202-4BAE-9045-7EC9944BF39FQ28270817-0CBAE33B-E94C-448F-BAFF-D6A345884D02Q29615376-F1DEADA9-8733-4062-8CD0-7D30A56B492DQ30653103-7CFF967C-B743-48B7-94E1-C8C1AAB037EEQ31044322-757DB10B-EBF6-453F-871E-ED76931267E8Q33203413-1EB28F29-09D9-4069-BC00-B5D51838F50AQ33431542-986E1855-DAFF-4298-9AB6-E032CD3E8E8CQ33560183-DD23E1D0-D149-49DD-9B7E-CB86CF4B3B09Q33563382-B704987E-70C9-4923-BCCA-3406B9C56F4AQ33591314-ED3338F2-2895-4887-901D-8457F2DDDE44Q33637285-A09ADAEF-3D34-4BA8-A855-F415BE490524Q33666600-A7F97E45-3592-456F-BDFC-7F7CB6E934F5Q33671809-6A3FF033-42DD-4972-881E-12D6C8812423Q33679013-959A10C6-8325-43CF-989A-267FB03BE8D8Q33683377-7667EFE0-FC56-4AB1-86B0-D296F90B8C14Q33695738-F9F4902F-2B73-42BE-A9E2-A6E239194E58Q33837669-68FC7AD0-753B-4D75-8B7F-2B240882F745Q33905494-9AD00D04-0D07-4410-8018-F4475D6749C6Q33934605-2BB3F298-FA64-4079-A05A-FAC8B3F37564Q33988553-1304CABF-003C-46BC-9205-F8A6BA0A6B19Q34002937-3B3D4025-82DF-4616-AC51-CD8D0DCAC61FQ34004313-402887B1-89A6-4BF4-827C-B6A3D93F71D9Q34004480-3C518834-CFFD-4ED9-AE31-3F12D5F1DDCFQ34097386-42108B99-0CEF-4CE2-8F76-435A11189D24Q34101325-F21CAEB9-7FFE-4F8D-8D99-05ACF1114C63Q34116194-E48416D7-091C-48A6-A5BB-3CB48FD8CA6BQ34171272-f2280c2a-4f50-a9f1-9740-ccfaa583ece7Q34171351-D2C67010-201B-445D-A438-CCCC6DC20A20Q34207044-1561EFFE-8554-427F-A12B-E4E26D4437B2Q34247824-536DD9A9-45E2-4503-948A-11967A5317E3Q34333511-EE7467C4-240F-42B0-BCEF-D2AB3D2D1BCFQ34348375-F2185F03-36D1-457B-88CB-5E51D88484F6Q34431032-BE458744-2A34-4A02-A7C2-65CA6842BECCQ34447497-03212247-F25D-4D3D-B268-2C9388F1FAE5Q34448672-E1315257-8D44-4A7B-A649-653FFE827E39
P50
description
onderzoeker
@nl
name
Mark A. Mintun
@ast
Mark A. Mintun
@da
Mark A. Mintun
@de
Mark A. Mintun
@en
Mark A. Mintun
@es
Mark A. Mintun
@fo
Mark A. Mintun
@fr
Mark A. Mintun
@is
Mark A. Mintun
@kl
Mark A. Mintun
@nb
type
label
Mark A. Mintun
@ast
Mark A. Mintun
@da
Mark A. Mintun
@de
Mark A. Mintun
@en
Mark A. Mintun
@es
Mark A. Mintun
@fo
Mark A. Mintun
@fr
Mark A. Mintun
@is
Mark A. Mintun
@kl
Mark A. Mintun
@nb
altLabel
M A Mintun
@da
M A Mintun
@de
M A Mintun
@en
Mark A Mintun
@da
Mark A Mintun
@de
Mark A Mintun
@en
Mark Mintun
@da
Mark Mintun
@de
Mark Mintun
@en
Mintun MA
@da
prefLabel
Mark A. Mintun
@ast
Mark A. Mintun
@da
Mark A. Mintun
@de
Mark A. Mintun
@en
Mark A. Mintun
@es
Mark A. Mintun
@fo
Mark A. Mintun
@fr
Mark A. Mintun
@is
Mark A. Mintun
@kl
Mark A. Mintun
@nb
P106
P21
P31
P6634
mark-mintun-0a29894a